| scholarly article | Q13442814 |
| P2093 | author name string | Kewal K Jain | |
| P2860 | cites work | Transdifferentiation-Induced Neural Stem Cells for the Treatment of Malignant Gliomas | Q48509691 |
| Dogs are man's best friend: in sickness and in health | Q48679475 | ||
| Extended field stereotactic radiosurgery for recurrent glioblastoma | Q48768943 | ||
| Intraoperative Photodynamic Diagnosis Using Talaporfin Sodium Simultaneously Applied for Photodynamic Therapy against Malignant Glioma: A Prospective Clinical Study. | Q49241839 | ||
| Fractionated Radiotherapy of Intracranial Gliomas | Q49381181 | ||
| The utilization of MGMT promoter methylation testing in United States hospitals for glioblastoma and its impact on prognosis. | Q50868147 | ||
| Iridium-Knife: Another knife in radiation oncology. | Q50924163 | ||
| Immune checkpoint blockade therapy. | Q52621721 | ||
| First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. | Q54941353 | ||
| Investigation of Newly Prepared Biodegradable 32P-chromic Phosphate-polylactide-co-glycolide Seeds and Their Therapeutic Response Evaluation for Glioma Brachytherapy. | Q55345094 | ||
| Recurrent Glioblastoma Treated with Recombinant Poliovirus. | Q55456747 | ||
| Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC. | Q55457095 | ||
| Radiotherapy after hyperbaric oxygenation for malignant gliomas: a pilot study. | Q55479992 | ||
| Real-Time Imaging of Brain Tumor for Image-Guided Surgery | Q57137254 | ||
| Exploiting Viruses to Treat Diseases | Q59358146 | ||
| Therapeutic Monoclonal Antibodies Delivery for the Glioblastoma Treatment | Q88430211 | ||
| Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona | Q89144231 | ||
| INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial | Q90571111 | ||
| [Stereotactic iodine-125 brachytherapy in the management of adult thalamic high grade gliomas] | Q90944385 | ||
| Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review | Q26739012 | ||
| Oncolytic virus therapy: A new era of cancer treatment at dawn | Q26739714 | ||
| Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma | Q27016552 | ||
| Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model. | Q27316967 | ||
| Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells | Q27318247 | ||
| Engineering a Brain Cancer Chip for High-throughput Drug Screening | Q27318558 | ||
| Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma. | Q27333831 | ||
| Stem Cell Transplantation Reverses Chemotherapy-Induced Cognitive Dysfunction | Q27347898 | ||
| A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study | Q27853118 | ||
| Concepts of immunotherapy for glioma | Q28083888 | ||
| What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas? | Q30989894 | ||
| Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy | Q33561644 | ||
| Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma | Q33816600 | ||
| Use of nanoparticles for cerebral cancer. | Q34012338 | ||
| Adenoviral vector-mediated gene therapy for gliomas: coming of age. | Q34022048 | ||
| Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients | Q34117487 | ||
| Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin. | Q34205345 | ||
| Inhibition of brain tumor growth by intravenous poly(β- l -malic acid) nanobioconjugate with pH-dependent drug release | Q34241230 | ||
| Cerebral hypoperfusion-assisted intra-arterial deposition of liposomes in normal and glioma-bearing rats | Q34756425 | ||
| Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy | Q34764143 | ||
| IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection | Q35059157 | ||
| Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression | Q35212521 | ||
| Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. | Q35356484 | ||
| Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation | Q35695799 | ||
| Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response | Q35779256 | ||
| Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets | Q35869744 | ||
| Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients | Q35878158 | ||
| Photodynamic Therapy for Malignant Brain Tumors | Q35926688 | ||
| Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord | Q35946342 | ||
| VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme | Q36096024 | ||
| Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma | Q36266545 | ||
| Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma | Q36523499 | ||
| Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 | ||
| ELTD1, a potential new biomarker for gliomas | Q36564447 | ||
| Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice | Q36634430 | ||
| Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. | Q36673354 | ||
| PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies | Q36693019 | ||
| Use of nanoparticles for drug delivery in glioblastoma multiforme | Q36787338 | ||
| Extended survival of glioblastoma patients after chemoprotective HSC gene therapy | Q36834118 | ||
| Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma | Q36887663 | ||
| Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan | Q37084982 | ||
| Migration of human neural stem cells toward an intracranial glioma | Q37184978 | ||
| miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma | Q37475020 | ||
| Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial | Q37492175 | ||
| Aptamer identification of brain tumor-initiating cells | Q37601425 | ||
| Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy | Q37861192 | ||
| Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas. | Q37981764 | ||
| Stem cell based glioblastoma gene therapy | Q38031961 | ||
| Nanobiotechnology-based strategies for crossing the blood-brain barrier | Q38038895 | ||
| Old but new methods in radiation oncology: hyperbaric oxygen therapy | Q38086801 | ||
| Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells | Q38104410 | ||
| Molecular genetics of gliomas | Q38180366 | ||
| Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment | Q38203283 | ||
| Targeting glioblastoma cancer stem cells: the next great hope? | Q38315676 | ||
| Canine brain tumours: a model for the human disease? | Q38491009 | ||
| Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives | Q38608016 | ||
| Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma | Q38635512 | ||
| Nanoparticles: Novel vehicles in treatment of Glioblastoma | Q38706430 | ||
| Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives. | Q38743138 | ||
| The role of bevacizumab in the treatment of glioblastoma | Q38773624 | ||
| Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers | Q38784169 | ||
| Targeted brain delivery nanoparticles for malignant gliomas. | Q38791884 | ||
| The therapeutic effect of photon irradiation on viable glioblastoma cells is reinforced by hyperbaric oxygen | Q38888665 | ||
| Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma | Q38888896 | ||
| Spatiotemporal genomic architecture informs precision oncology in glioblastoma | Q38927317 | ||
| Neural stem cell-based gene therapy for brain tumors | Q39137284 | ||
| Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors | Q39347239 | ||
| The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma. | Q39466558 | ||
| Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods | Q39540447 | ||
| Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells | Q39697091 | ||
| Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles | Q39891510 | ||
| EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise. | Q40089704 | ||
| Future prospects for the cure of brain cancer | Q40325527 | ||
| Development of an integrated Monte Carlo model for glioblastoma multiforme treated with boron neutron capture therapy | Q41204233 | ||
| Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy | Q41485890 | ||
| Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir | Q41576545 | ||
| Clinical implications of microRNAs in human glioblastoma | Q41872498 | ||
| MicroRNAs in Human Malignant Gliomas | Q42242451 | ||
| Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial | Q42284125 | ||
| Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy | Q42289519 | ||
| Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients | Q42637759 | ||
| Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline | Q45270171 | ||
| Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy | Q45864012 | ||
| Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma | Q45887455 | ||
| A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. | Q45946525 | ||
| FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells | Q46496221 | ||
| 14-3-3ζ positive expression is associated with a poor prognosis in patients with glioblastoma | Q46717742 | ||
| Current trends in mouse models of glioblastoma. | Q47169542 | ||
| Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells | Q47433580 | ||
| Intraoperative imaging technology to maximise extent of resection for glioma. | Q47848195 | ||
| Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand? | Q47986822 | ||
| Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma. | Q48018806 | ||
| MiR-21: A key player in glioblastoma pathogenesis. | Q48095332 | ||
| Faithful companions: a proposal for neurooncology trials in pet dogs | Q48164021 | ||
| Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization | Q48319430 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| cancer research | Q3421914 | ||
| P304 | page(s) | 419 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | A Critical Overview of Targeted Therapies for Glioblastoma | |
| P478 | volume | 8 |
| Q92993547 | ARL3 is downregulated and acts as a prognostic biomarker in glioma |
| Q96128464 | Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity |
| Q90056646 | Development of an Immune Infiltration-Related Prognostic Scoring System Based on the Genomic Landscape Analysis of Glioblastoma Multiforme |
| Q97543194 | Dissecting and rebuilding the glioblastoma microenvironment with engineered materials |
| Q91974737 | Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway |
| Q95270485 | Enhanced Anti-Glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles |
| Q89493323 | Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models |
| Q92675121 | Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells |
| Q93088940 | Neural Stem Cells of the Subventricular Zone as the Origin of Human Glioblastoma Stem Cells. Therapeutic Implications |
| Q91642501 | Recurrent or Refractory High-Grade Gliomas Treated by Convection-Enhanced Delivery of a TGFβ2-Targeting RNA Therapeutic: A Post-Hoc Analysis with Long-Term Follow-Up |
| Q90401711 | Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns |
| Q90682138 | Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis |
| Q90211010 | Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis |
| Q98499768 | Vesiclemia: counting on extracellular vesicles for glioblastoma patients |
Search more.